The prevalence of breakthrough infection among healthcare workers post-coronavirus disease 2019 vaccination in Jazan Region: A retrospective study.
Saved in:
| Title: | The prevalence of breakthrough infection among healthcare workers post-coronavirus disease 2019 vaccination in Jazan Region: A retrospective study. |
|---|---|
| Authors: | Mohamed, Amal H. (AUTHOR), Abdalghani, Nagla (AUTHOR) |
| Source: | Saudi Journal for Health Sciences. Jan-Apr2025, Vol. 14 Issue 1, p42-48. 7p. |
| Subjects: | Medical personnel, Breakthrough infections, COVID-19, Hospital medical staff, Nurses |
| Abstract: | Background: It has been reported that vaccination with several vaccines has been associated with significant infections after immunization, despite being one of the most effective strategies against coronavirus disease 2019 (COVID-19). Aims: The aim of this study was to examine the incidence of postvaccination breakthrough infection, manifestations, and disease severity. Setting and Design: This study examines the incidence of breakthrough infection after COVID-19 vaccination among medical staff at Al-Hayat Hospital in the Jazan Region of Saudi Arabia. Participants must have received at least two doses of the Pfizer or AstraZeneca vaccines. Materials and Methods: From March to December 2022, medical records of healthcare workers (HCWs) who tested positive for COVID-19 after vaccination were obtained. According to predefined criteria, records were reviewed, and symptoms and polymerase chain reaction tests were used to confirm infections. Statistical Analysis: The data were entered and analyzed using the IBM Statistical Package for the Social Sciences (SPSS) software version 21.0. A statistically significant P value was defined as < 0.05. Results: 98.4% of 444 HCWs received the AstraZeneca vaccine, while 1.6% received Pfizer. An average age of 33.8 years was found, with 64.6% of women and 38.5% of nurses. Twelve percent had previously contracted COVID-19. Physicians and medical records professionals (25.6% each) and nurses (20.6%) were most likely to contract COVID-19 after vaccination. Thirty-nine participants (2.6%) were infected and only one required brief hospitalization. Conclusions: Despite breakthrough infections, the study shows that vaccines effectively reduce severe outcomes. Risk stratification of COVID-19 breakthrough infections requires future research that accounts for co-occurring infections and virus variations. [ABSTRACT FROM AUTHOR] |
| Copyright of Saudi Journal for Health Sciences is the property of Wolters Kluwer India Pvt Ltd and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | Background: It has been reported that vaccination with several vaccines has been associated with significant infections after immunization, despite being one of the most effective strategies against coronavirus disease 2019 (COVID-19). Aims: The aim of this study was to examine the incidence of postvaccination breakthrough infection, manifestations, and disease severity. Setting and Design: This study examines the incidence of breakthrough infection after COVID-19 vaccination among medical staff at Al-Hayat Hospital in the Jazan Region of Saudi Arabia. Participants must have received at least two doses of the Pfizer or AstraZeneca vaccines. Materials and Methods: From March to December 2022, medical records of healthcare workers (HCWs) who tested positive for COVID-19 after vaccination were obtained. According to predefined criteria, records were reviewed, and symptoms and polymerase chain reaction tests were used to confirm infections. Statistical Analysis: The data were entered and analyzed using the IBM Statistical Package for the Social Sciences (SPSS) software version 21.0. A statistically significant P value was defined as < 0.05. Results: 98.4% of 444 HCWs received the AstraZeneca vaccine, while 1.6% received Pfizer. An average age of 33.8 years was found, with 64.6% of women and 38.5% of nurses. Twelve percent had previously contracted COVID-19. Physicians and medical records professionals (25.6% each) and nurses (20.6%) were most likely to contract COVID-19 after vaccination. Thirty-nine participants (2.6%) were infected and only one required brief hospitalization. Conclusions: Despite breakthrough infections, the study shows that vaccines effectively reduce severe outcomes. Risk stratification of COVID-19 breakthrough infections requires future research that accounts for co-occurring infections and virus variations. [ABSTRACT FROM AUTHOR] |
|---|---|
| ISSN: | 22781900 |
| DOI: | 10.4103/sjhs.sjhs_116_24 |
